
Microsatellite expansion, such as trinucleotide repeat expansion (TRE), is known to cause a number of genetic diseases. Sanger sequencing and next-generation short-read sequencing are unable to interrogate TRE reliably. We developed a novel algorithm called RepeatHMM to estimate repeat counts from long-read sequencing data. Evaluation on simulation data, real amplicon sequencing data on two repeat expansion disorders, and whole-genome sequencing data generated by PacBio and Oxford Nanopore technologies showed superior performance over competing approaches. We concluded that long-read sequencing coupled with RepeatHMM can estimate repeat counts on microsatellites and can interrogate the "unsequenceable" genomic trinucleotide repeat disorders.
PacBio, Nanopore, R, Method, High-Throughput Nucleotide Sequencing, Trinucleotide repeats, Sequence Analysis, DNA, QH426-470, RepeatHMM, Trinucleotide repeat disorders, Trinucleotide Repeats, Genetics, Medicine, Humans, Microsatellites, Algorithms
PacBio, Nanopore, R, Method, High-Throughput Nucleotide Sequencing, Trinucleotide repeats, Sequence Analysis, DNA, QH426-470, RepeatHMM, Trinucleotide repeat disorders, Trinucleotide Repeats, Genetics, Medicine, Humans, Microsatellites, Algorithms
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 84 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
